CDx Diagnostics Appoints Industry Leader Bill Huffnagle as Chief Executive Officer
07 mai 2019 08h00 HE
|
CDx Diagnostics
- Leadership transition underscores significant commercial opportunity for WATS3D - - Wide-scale adoption of WATS3D is helping make esophageal adenocarcinoma, one of the most rapidly growing cancers...
Helping to Add Esophageal Adenocarcinoma to the List of Preventable Cancers
12 avr. 2019 09h00 HE
|
CDx Diagnostics
- Early detection of Barrett’s esophagus and dysplasia with WATS3D offers new solution to one of the most rapidly growing and fatal cancers in the United States - SUFFERN, N.Y., April 12, 2019 ...
WATS3D Markedly Improves Detection of Esophageal Dysplasia and Barrett’s Esophagus in 12,899 Patient Study in the “Real World” Practice setting of 58 Community-Based Gastroenterologists
20 déc. 2018 09h00 HE
|
CDx Diagnostics
- New Study with Largest Data Set to Date Demonstrates that Adjunctive Use of WATS3D Significantly Increases Detection of Esophageal Precancer - - Study Published in Diseases of the Esophagus - ...
CDx Diagnostics to Present New WATS3D Data Confirming Crypt Dysplasia as a Risk Factor for Esophageal Cancer in Patients With Barrett’s Esophagus
08 oct. 2018 08h00 HE
|
CDx Diagnostics
- Data Presented at ACG 2018 Presidential Plenary Session Underscores the Value of Using WATS3D to Ensure Accurate Risk Stratification of BE Patients to Reduce Esophageal Cancer Deaths - SUFFERN,...
Multicenter Prospective Study of More Than 4,000 Patients Shows WATS3D Increases Detection of Pre-Cancerous Changes in the Esophagus by Over 80%
22 mars 2018 09h00 HE
|
CDx Diagnostics
– Data published in United European Gastroenterology Journal and featured in new ASGE Tech Talk video – SUFFERN, N.Y., March 22, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, developer of WATS3D, or...
CDx Diagnostics Announces Appointment of New CFO and Executive Vice President of Managed Care
06 mars 2018 09h00 HE
|
CDx Diagnostics
New Senior Leadership Sets Trajectory for 2018 WATS3D Commercial Expansion SUFFERN, N.Y., March 06, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, an innovator in computer synthesized 3D tissue analysis...